CIK 2032331
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Institutional 13F holdings & portfolio
Holdings
104
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
2
Holdings
13F filings as of Dec 31, 2025 · Showing 51–100 of 104
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| PFE | PFIZER INC | 43K | $1M+ | SH |
| TIP | ISHARES TR | 9K | $500K+ | SH |
| PEN | PENUMBRA INC | 3K | $500K+ | SH |
| COO | COOPER COS INC | 10K | $500K+ | SH |
| NVS | NOVARTIS AG | 6K | $500K+ | SH |
| SE | SEA LTD | 7K | $500K+ | SH |
| CRL | CHARLES RIV LABS INTL INC | 4K | $500K+ | SH |
| TMO | THERMO FISHER SCIENTIFIC INC | 1K | $500K+ | SH |
| PTCT | PTC THERAPEUTICS INC | 9K | $500K+ | SH |
| ASND | ASCENDIS PHARMA A/S | 3K | $500K+ | SH |
| AXGN | AXOGEN INC | 19K | $500K+ | SH |
| AZTA | AZENTA INC | 19K | $500K+ | SH |
| PRAX | PRAXIS PRECISION MEDICINES I | 2K | $500K+ | SH |
| EEM | ISHARES TR | 11K | $500K+ | SH |
| FTRE | FORTREA HLDGS INC | 34K | $500K+ | SH |
| BMY | BRISTOL-MYERS SQUIBB CO | 11K | $500K+ | SH |
| AVGO | BROADCOM INC | 2K | $500K+ | SH |
| BIO | BIO RAD LABS INC | 2K | $500K+ | SH |
| GDX | VANECK ETF TRUST | 6K | $500K+ | SH |
| OMCL | OMNICELL COM | 12K | $500K+ | SH |
| MEDP | MEDPACE HLDGS INC | 908 | $500K+ | SH |
| BIIB | BIOGEN INC | 3K | $500K+ | SH |
| NBIX | NEUROCRINE BIOSCIENCES INC | 4K | $100K–$500K | SH |
| BLTE | BELITE BIO INC | 3K | $100K–$500K | SH |
| APGE | APOGEE THERAPEUTICS INC | 6K | $100K–$500K | SH |
| SYRE | SPYRE THERAPEUTICS INC | 14K | $100K–$500K | SH |
| GOOGL | ALPHABET INC | 1K | $100K–$500K | SH |
| XLI | SELECT SECTOR SPDR TR | 3K | $100K–$500K | SH |
| RYAAY | RYANAIR HOLDINGS PLC | 5K | $100K–$500K | SH |
| WRBY | WARBY PARKER INC | 18K | $100K–$500K | SH |
| AXSM | AXSOME THERAPEUTICS INC | 2K | $100K–$500K | SH |
| IMVT | IMMUNOVANT INC | 14K | $100K–$500K | SH |
| VCSH | VANGUARD SCOTTSDALE FDS | 4K | $100K–$500K | SH |
| NVST | ENVISTA HOLDINGS CORPORATION | 15K | $100K–$500K | SH |
| TWST | TWIST BIOSCIENCE CORP | 10K | $100K–$500K | SH |
| SOXX | ISHARES TR | 1K | $100K–$500K | SH |
| CYTK | CYTOKINETICS INC | 4K | $100K–$500K | SH |
| DYN | DYNE THERAPEUTICS INC | 14K | $100K–$500K | SH |
| APLS | APELLIS PHARMACEUTICALS INC | 11K | $100K–$500K | SH |
| ACAD | ACADIA PHARMACEUTICALS INC | 10K | $100K–$500K | SH |
| COGT | COGENT BIOSCIENCES INC | 7K | $100K–$500K | SH |
| VTYX | VENTYX BIOSCIENCES INC | 28K | $100K–$500K | SH |
| RVMD | REVOLUTION MEDICINES INC | 3K | $100K–$500K | SH |
| TERN | TERNS PHARMACEUTICALS INC | 6K | $100K–$500K | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 6K | $100K–$500K | SH |
| BBIO | BRIDGEBIO PHARMA INC | 3K | $100K–$500K | SH |
| CRNX | CRINETICS PHARMACEUTICALS IN | 5K | $100K–$500K | SH |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 371 | $100K–$500K | SH |
| NKTR | NEKTAR THERAPEUTICS | 5K | $100K–$500K | SH |
| ABVX | ABIVAX SA | 1K | $100K–$500K | SH |